Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide
- 1 April 1983
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 40 (1) , 257-264
- https://doi.org/10.1128/iai.40.1.257-264.1983
Abstract
The bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide was investigated as a function of the complement source. The IgM murine monoclonal antibody 2-2-B was shown by several different methods to be highly specific for meningococcal group B and Escherichia coli K1 capsular polysaccharides. It had strong bactericidal activity in conjunction with rabbit or human complement, but gave a higher titer with rabbit complement. A strong prozone was observed in each case. Human postvaccination antibody to meningococcal group B polysaccharide was strongly bactericidal with rabbit complement, but had little or no bactericidal activity in conjuction with human complement. Antibodies in adult normal human sera that were bactericidal with rabbit complement were also predominantly directed against the meningococcal group B capsular polysaccharide. Human antibodies that were bactericidal with human complement appeared to be primarily directed against noncapsular antigens.This publication has 32 references indexed in Scilit:
- ELISA methodology for polysaccharide antigens: Protein coupling of polysaccharides for adsorption to plastic tubesJournal of Immunological Methods, 1979
- Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in ManJournal of Clinical Investigation, 1979
- Development of Antibodies to Meningococcal Protein and Lipopolysaccharide Serotype Antigens in Healthy CarriersJournal of Medical Microbiology, 1979
- Immunoepidemiology of Meningococcal Disease in Military Recruits. II. Blocking of Serum Bactericidal Activity by Circulating IgA Early in the Course of Invasive DiseaseThe Journal of Infectious Diseases, 1977
- Role of Protein Serotype Antigens in Protection against Disease Due to Neisseria meningitidisThe Journal of Infectious Diseases, 1977
- Standardization and control of meningococcal vaccines, group A and group C polysaccharidesJournal of Biological Standardization, 1977
- Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitisThe Journal of Pediatrics, 1976
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969